Prelude Capital Management’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-18,378
| Closed | -$95K | – | 1815 |
|
|
2019
Q2 | $95K | Buy |
18,378
+16,173
| +733% | +$83.6K | ﹤0.01% | 654 |
|
|
2019
Q1 | $8K | Sell |
2,205
-440
| -17% | -$1.6K | ﹤0.01% | 1188 |
|
|
2018
Q4 | $16K | Buy |
2,645
+491
| +23% | +$2.97K | ﹤0.01% | 957 |
|
|
2018
Q3 | $13K | Sell |
2,154
-484
| -18% | -$2.92K | ﹤0.01% | 1062 |
|
|
2018
Q2 | $11K | Buy |
2,638
+448
| +20% | +$1.87K | ﹤0.01% | 1195 |
|
|
2018
Q1 | $10K | Buy |
2,190
+1,140
| +109% | +$5.21K | ﹤0.01% | 1205 |
|
|
2017
Q4 | $6K | Buy |
+1,050
| New | +$6K | ﹤0.01% | 1119 |
|
|
2016
Q4 | – | Sell |
-1,800
| Closed | -$17K | – | 1845 |
|
|
2016
Q3 | $17K | Buy |
+1,800
| New | +$17K | ﹤0.01% | 1295 |
|
|
2016
Q1 | – | Sell |
-21,177
| Closed | -$118K | – | 1580 |
|
|
2015
Q4 | $118K | Sell |
21,177
-11,397
| -35% | -$63.5K | 0.02% | 704 |
|
|
2015
Q3 | $276K | Buy |
32,574
+21,374
| +191% | +$181K | 0.04% | 415 |
|
|
2015
Q2 | $169K | Buy |
11,200
+2,900
| +35% | +$43.8K | 0.02% | 643 |
|
|
2015
Q1 | $133K | Buy |
8,300
+300
| +4% | +$4.81K | 0.02% | 837 |
|
|
2014
Q4 | $143K | Hold |
8,000
| – | – | 0.02% | 803 |
|
|
2014
Q3 | $80K | Hold |
8,000
| – | – | 0.01% | 1101 |
|
|
2014
Q2 | $125K | Hold |
8,000
| – | – | 0.02% | 892 |
|
|
2014
Q1 | $148K | Hold |
8,000
| – | – | 0.02% | 742 |
|
|
2013
Q4 | $153K | Hold |
8,000
| – | – | 0.03% | 628 |
|
|
2013
Q3 | $131K | Buy |
+8,000
| New | +$131K | 0.02% | 601 |
|